Addressing Metabolic Dysfunction‑Associated Steatotic Liver Disease (MASLD) in Endocrinology Settings in Canada: From Prevalence to Patient-Centered Management. (2025). Canadian Diabetes & Endocrinology Today, 3(s01), 2–8. https://doi.org/10.58931/cdet.2025.3s0144